10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0001439222-23-000119`
Period End Date	20230630
Filing Date	20230803
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	agio-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 58 Cash Flow Statement 64 Stockholders Equity 39 Comprehensive Income 14

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$84.75M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$139.26M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$643.86M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$617.81M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$2.21M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`ContractWithCustomerAssetNetCurrent`	$2.25M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Inventory	`InventoryNet`	$8.49M	USD	Point-in-time
Inventory	`InventoryNet`	$15.67M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$36.75M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$38.95M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	71.26M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	71.95M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	55.73M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	55.04M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$832.77M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$757.24M	USD	Point-in-time
Treasury stock, common (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$313.87M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$244.36M	USD	Point-in-time
Treasury stock, common (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$65.13M	USD	Point-in-time
Operating lease assets	`OperatingLeaseRightOfUseAsset`	$59.87M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$19.63M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.96M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.06M	USD	Point-in-time
Total assets	`Assets`	$1.24B	USD	Point-in-time
Total assets	`Assets`	$1.09B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$18.62M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.63M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$29.19M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$30.35M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$14.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$13.66M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$62.63M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$55.14M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$64.62M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$72.00M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.16M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.28M	USD	Point-in-time
Total liabilities	`Liabilities`	$120.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$137.90M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,951,186 shares issued and 55,734,775 shares outstanding at June 30, 2023, and 71,256,118 shares issued and 55,039,707 shares outstanding at December 31, 2022	`CommonStockValueOutstanding`	$72.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 71,951,186 shares issued and 55,734,775 shares outstanding at June 30, 2023, and 71,256,118 shares issued and 55,039,707 shares outstanding at December 31, 2022	`CommonStockValueOutstanding`	$71.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.39B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.41B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-12.54M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-8.87M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at June 30, 2023 and December 31, 2022)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Treasury stock, at cost (16,216,411 shares at June 30, 2023 and December 31, 2022)	`TreasuryStockValue`	$802.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-635.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-470.56M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.10B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.04B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.29B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.12B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.21B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$964.24M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.09B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.24B	USD	Point-in-time

Income Statement 58 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.71M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.58M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$12.32M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.41M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.11M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$774.00K	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.66M	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$435.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$74.52M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$136.20M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$144.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$68.89M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$58.78M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$28.26M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$59.78M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$30.41M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$196.63M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$103.22M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$205.20M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$100.41M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-198.78M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-184.31M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-97.64M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-93.70M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`RoyaltyIncomeNonoperating`	-	USD	2 Qtrs
Royalty income from gain on sale of oncology business	`RoyaltyIncomeNonoperating`	$2.70M	USD	1 Quarter
Royalty income from gain on sale of oncology business	`RoyaltyIncomeNonoperating`	-	USD	1 Quarter
Royalty income from gain on sale of oncology business	`RoyaltyIncomeNonoperating`	$5.41M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeNet`	$8.25M	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$1.79M	USD	1 Quarter
Interest income, net	`InvestmentIncomeNet`	$16.34M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeNet`	$2.49M	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.64M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$4.31M	USD	2 Qtrs
Other income, net	`OtherNonoperatingIncomeExpense`	$1.34M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$3.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-186.58M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-164.82M	USD	2 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.68	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-1.51	USD	1 Quarter
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-3.41	USD	2 Qtrs
Net (loss) income per share - basic (in usd per share)	`EarningsPerShareBasic`	$-2.97	USD	2 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-2.97	USD	2 Qtrs
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.68	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.51	USD	1 Quarter
Net (loss) income per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$-3.41	USD	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.60M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.68M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	55.44M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	54.80M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.60M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.68M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	54.80M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share from continuing operations, net (loss) income from discontinued operations and net (loss) income per share - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	55.44M	shares	2 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-186.58M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-164.82M	USD	2 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$4.77M	USD	2 Qtrs
Depreciation and amortization	`OtherDepreciationAndAmortization`	$3.60M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$26.68M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$21.88M	USD	2 Qtrs
Net (accretion of discount) amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.38M	USD	2 Qtrs
Net (accretion of discount) amortization of premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.74M	USD	2 Qtrs
(Gain) loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-10.00K	USD	2 Qtrs
(Gain) loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$150.00K	USD	2 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$5.26M	USD	2 Qtrs
Non-cash operating lease expense	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$4.92M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$45.00K	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.60M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$7.18M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$4.06M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	-	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-1.67M	USD	2 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.10M	USD	2 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.56M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.84M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-7.24M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.16M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.58M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-5.55M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-6.71M	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$779.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-2.12M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-171.96M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-161.93M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$232.49M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$607.75M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$337.45M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$668.72M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.73M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$396.00K	USD	2 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$150.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$56.24M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$104.72M	USD	2 Qtrs
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	$164.00K	USD	2 Qtrs
Payments on financing lease obligations	`FinanceLeasePrincipalPayments`	-	USD	2 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$1.30M	USD	2 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$2.70M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.14M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.70M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-114.58M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-54.51M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.75M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.54M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.75M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$203.13M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.54M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.26M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$6.00K	USD	2 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$11.00K	USD	2 Qtrs
Cash taxes paid	`IncomeTaxesPaid`	$801.00K	USD	2 Qtrs
Cash taxes paid	`IncomeTaxesPaid`	$1.84M	USD	2 Qtrs

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	55.73M	shares	Point-in-time
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	55.04M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.12B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$964.24M	USD	Point-in-time
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-2.76M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-6.55M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$-459.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax`	$4.12M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	152,849.00	shares	2 Qtrs
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$238.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$15.00K	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.29M	USD	1 Quarter
Common stock issued under stock incentive plan and ESPP	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.47M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.51M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.16M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.14M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.74M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-186.58M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-164.82M	USD	2 Qtrs
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	55.73M	shares	Point-in-time
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	55.04M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	16.22M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$1.10B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.04B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.29B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.12B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$1.21B	USD	Point-in-time
Ending balance	`StockholdersEquity`	$964.24M	USD	Point-in-time

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-83.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.02M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.81M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-94.77M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-186.58M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-164.82M	USD	2 Qtrs
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-459.00K	USD	1 Quarter
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-9.30M	USD	2 Qtrs
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.67M	USD	2 Qtrs
Unrealized (loss) gain on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.76M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-195.88M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-94.56M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-84.27M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-161.16M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.